Personalized Immunotherapy Combinations on Horizon

Future development of novel immunotherapy combinations should be based on individual patient characteristics, such as patient-level immune targets and tumor microenvironment, according to a presentation by Jason Luke, MD, at the 36th Annual CFS.11/09/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news